A study to assess the predominance of sycotic miasmatic manifestations in the cases of uterine fibroid
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- To assess the predominance of sycotic miasmatic manifestations in
研究概览
简要总结
Uterine fibroid or Leiomyomas are the most common benign tumors of the uterus and also the most common benign solid tumor in female. Histologically,the tumor is composed of smooth muscle and fibrous connective tissue. Uterine fibroid represent a significant gynecological concern worldwide of women during reproductive years. (Reproductive age 15-49years according to WHO). Although they are benign, mostly asymptomatic, they can have a significant influence on a woman’s health and quality of life, showing up as pelvic discomfort, or heavy menstrual bleeding and reproductive challenges such as recurrent pregnancy loss.
At the end the study we may expect the dominance of sycotic miasm in cases of Uterine fibroid. The result of study will provide a deeper understanding of the role of the miasm in the pathophysiology and management of uterine fibroids, contributing to the scientific foundation of miasmatic theory in homeopathy. The miasmatic analysis can be helpful in anti-miasmatic prescription that will results in permanent restoration of health. By addressing the underlying miasmatic predisposition, the study emphasizes a holistic approach that treats the patient as a whole, rather than focusing solely on symptoms or pathology.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 15.00 Year(s) 至 49.00 Year(s)(—)
- 性别
- Female
入选标准
- •1-Women with diagnosed cases of Uterine fibroid.
- •2-Presence of any of the symptoms such as :Abnormal Uterine bleeding (profuse menstruation or intercyclic menstruation) :Pelvic heaviness :Pain during menstruation :Pressure symptoms such as urinary frequency, constipation.
- •3-Participants must provide informed consent, adhere to study protocols, and attend scheduled visits.
排除标准
- •1-Pregnant and lactating women.
- •2- Presence of any other pelvic pathology.
- •3-Cases suffering from severe systemic illnesses or any other life threatening conditions.
- •4- Patient undergoing any other treatment for fibroid.
- •5-Patient who are not willing to come for follow ups.
结局指标
主要结局
To assess the predominance of sycotic miasmatic manifestations in
时间窗: 6 months
patients with uterine fibroid.
时间窗: 6 months
次要结局
- To assess the effectiveness of individualised homoeopathic medicine in reducing the size of uterine fibroid and improvement in quality of life using Uterine Fibroid Symptom Health Related Quality of Life Questionnaire(UFSQoL).(6 months)
研究者
Dr Varsha karanjia
State National Homoeopathic Medical college and Hospital lucknow
